<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiomes</journal-id>
<journal-title>Frontiers in Microbiomes</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiomes</abbrev-journal-title>
<issn pub-type="epub">2813-4338</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/frmbi.2023.1249518</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiomes</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Causal effects of gut microbiota on the risk of bipolar disorder: a Mendelian randomization study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Ran</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2307358"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Shuo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Lu-yi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Guang-cheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1183473"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fang</surname>
<given-names>Bo-qin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Xin-jun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Urology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University</institution>, <addr-line>Xiamen</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Urology, Zhongshan Hospital Xiamen University, The School of Clinical Medicine, Fujian Medical University</institution>, <addr-line>Xiamen</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Lai (Lisa) Wei, Cedars Sinai Medical Center, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Shenghui Li, Puensum Genetech Institute, China; Shudi Li, University of Texas Health Science Center at Houston, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xin-jun Wang, <email xlink:href="mailto:wxj@xmu.edu.cn">wxj@xmu.edu.cn</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>2</volume>
<elocation-id>1249518</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Xu, Liu, Li, Zhang, Luo, Fang and Wang</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Xu, Liu, Li, Zhang, Luo, Fang and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Recent studies have suggested a possible association between gut microbiota and bipolar disorder (BD). However, observational studies are limited and there are variations between the gut microbiota taxa found in different studies. Therefore, we aimed to explore whether there is a causal relationship between gut microbiota and bipolar disorder at the genetic level and to reveal trends in the effect of influential gut microbiota on the development of bipolar disorder.</p>
</sec>
<sec>
<title>Methods</title>
<p>We conducted a Mendelian randomisation (MR) study of summary statistics from a genome-wide association study (GWAS) of gut microbiota and bipolar disorder. Inverse variance weighting (IVW) was used as the primary method of statistical analysis, while results from the MR-Egger method, weighted median, weighted mode, and MR multiplicity residuals and outliers (MR-PRESSO) tests were used for additional validation.Cochrane&#x2019;s Q test, MR-Egger intercept test, and MR-PRESSO global test were used to test MR results for stability and reliability.</p>
</sec>
<sec>
<title>Result</title>
<p>We identified 13 gut microbial taxa causally associated with bipolar disorder. Betaproteobacteria, Acidaminococcaceae, Eubacterium xylanophilum group, Butyricimonas, Peptococcus, Prevotella 7, Roseburia, Terrisporobacter, Burkholderiales and Desulfovibrionales increased the risk of BD, whereas Candidatus Soleaferrea, Ruminiclostridium 5 and Victivallis decreased the risk of BD. The results of the MR analysis were shown to be reliable in the sensitivity analysis.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>With the MR study, we analysed the causal relationship between 196 gut microbial taxa and bipolar disorder and also identified gut microbiota associated with the risk of developing bipolar disorder. Our findings provide new biomarkers and potential therapeutic targets for the prevention and treatment of BD.</p>
</sec>
</abstract>
<kwd-group>
<kwd>gut microbiota</kwd>
<kwd>bipolar disorder</kwd>
<kwd>mendelian randomization</kwd>
<kwd>causal relationship</kwd>
<kwd>MiBioGen</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="54"/>
<page-count count="10"/>
<word-count count="3498"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Host and Microbe Associations</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Bipolar disorder (BD) is a psychiatric disorder characterised by alternating recurrent episodes of depression and mania, changes in activity levels and associated physical, psychological, cognitive and behavioural abnormalities.BD is a highly heterogeneous disorder of unknown aetiology (<xref ref-type="bibr" rid="B33">McIntyre et&#xa0;al., 2020</xref>). BD affects approximately 2% of the world&#x2019;s population and represents a significant global public health burden (<xref ref-type="bibr" rid="B28">Lu et&#xa0;al., 2023</xref>). Although the disorder has been extensively studied from the perspectives of disease genetics, behaviour, physiopathology and imaging, no significant advances have been made (<xref ref-type="bibr" rid="B42">Sigitova et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B48">Vieta et&#xa0;al., 2018</xref>). Therefore, research into the aetiology of BD and the prevention of BD from its early onset has become increasingly important.</p>
<p>The gut microbiota is a collective of a large number of bacteria that live in the human gut. In recent years, a large body of research has demonstrated not only the important role of the gut microbiota in regulating metabolism and immune activity in the human body (<xref ref-type="bibr" rid="B13">Delzenne et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B32">Maynard et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B25">Lee et&#xa0;al., 2020</xref>), but also the close association with metabolic diseases, autoimmune diseases, tumours and many other diseases (<xref ref-type="bibr" rid="B14">Fan and Pedersen, 2021</xref>; <xref ref-type="bibr" rid="B39">Park et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B35">Miyauchi et&#xa0;al., 2023</xref>). The role of the gut microbiota in psychiatric disorders has also received increasing attention as the gut-brain axis continues to be studied (<xref ref-type="bibr" rid="B36">Nikolova et&#xa0;al., 2021</xref>). Compared to healthy individuals, there are significant changes in gut microbial composition or metabolic function in patients with BD (<xref ref-type="bibr" rid="B38">Painold et&#xa0;al., 2019</xref>). In addition, gut microbes are involved in the activation of focal inflammatory responses (<xref ref-type="bibr" rid="B9">Caruso et&#xa0;al., 2020</xref>), and similar inflammatory changes are significant in BD (<xref ref-type="bibr" rid="B20">Kirkpatrick and Miller, 2013</xref>). At the same time, gut microbes can directly or indirectly produce neurotransmitters such as GABA and 5-HT (<xref ref-type="bibr" rid="B8">Busnelli et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B40">Patterson et&#xa0;al., 2019</xref>), and the regulation of mood by these neurotransmitters has long been supported by previous studies (<xref ref-type="bibr" rid="B30">Mahar et&#xa0;al., 2014</xref>). These findings suggest a potential link between the gut microbiota and BD.</p>
<p>Mendelian randomization (MR) is a data analysis method for evaluating aetiological inference in epidemiological studies that uses genetic variation as an instrumental variable (IV) to estimate the causal relationship between the exposure factor of interest and the outcome of interest (<xref ref-type="bibr" rid="B12">Davies et&#xa0;al., 2018</xref>). MR uses Mendel&#x2019;s first and second laws of inheritance, where parental alleles are randomly assigned to offspring, so that the relationship between genes and outcomes is not confounded by common confounders such as postnatal environment, socioeconomics and behavioural habits (<xref ref-type="bibr" rid="B23">Lawlor et&#xa0;al., 2008</xref>). MR can overcome the limitations of observational studies and is increasingly being used to study psychiatric disorders (<xref ref-type="bibr" rid="B11">Daghlas et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B41">Rosoff et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B16">Guo et&#xa0;al., 2022</xref>). Therefore, MR is an ideal technique to explore the causal relationship between gut microbiota and BD.</p>
<p>Therefore, based on summary statistics from a large genome-wide association study (GWAS) dataset, we used MR analysis to explore potential causal relationships between gut microbiota and BD, and to identify taxa with potential impact on BD.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Study design</title>
<p>The overall design of this study is shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. Mendelian randomisation studies must meet three core assumptions of correlation, independence and exclusivity, namely: (1) instrumental variables must be highly correlated with exposure factors, (2) instrumental variables must not be correlated with any confounding factors associated with &#x2018;exposure-outcome&#x2019;, and (3) instrumental variables can only influence outcome variables through exposure factors (<xref ref-type="bibr" rid="B5">Burgess et&#xa0;al., 2017</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Overall design of this study.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="frmbi-02-1249518-g001.tif"/>
</fig>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Data sources</title>
<p>Genetic association data for the gut microbiota were obtained from a large GWAS study by the MiBioGen consortium (<ext-link ext-link-type="uri" xlink:href="https://mibiogen.gcc.rug.nl">https://mibiogen.gcc.rug.nl</ext-link>), which included 18,340 participants from 11 countries. After removing 15 unknown bacterial taxa, we ended up with 9 phyla, 16 classes, 20 orders, 32 families and 119 genera, for a total of 196 taxa (<xref ref-type="supplementary-material" rid="SM1">
<bold>Table S1</bold>
</xref>) (<xref ref-type="bibr" rid="B21">Kurilshikov et&#xa0;al., 2021</xref>). GWAS summary statistics for BD were obtained from the IEU GWAS database (<ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/">https://gwas.mrcieu.ac.uk/</ext-link>), a dataset (ieu-b-41) containing 20,352 cases of European ancestry and 31,358 controls of European ancestry. All patients with BD fulfilled international consensus criteria (DSM-IV or ICD-10) (<xref ref-type="bibr" rid="B43">Stahl et&#xa0;al., 2019</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Selection of instrumental variables</title>
<p>First, we extracted SNPs closely associated with gut microbiota from the GWAS study data using a threshold of P&lt;1&#xd7;10<sup>-5</sup> (<xref ref-type="bibr" rid="B53">Zeng et&#xa0;al., 2023</xref>). In addition, to ensure the independence of each IV, we used a threshold of r<sup>2</sup>&lt;0.001 and a window size of 10,000 kb to mitigate linkage disequilibrium (<xref ref-type="bibr" rid="B53">Zeng et&#xa0;al., 2023</xref>). At the same time, palindromic SNPs and SNPs not present in the results were also removed from the IVs. Finally, SNPs with an F-statistic &lt;10 were removed to eliminate bias caused by weak instrumental variables in the results (<xref ref-type="bibr" rid="B6">Burgess and Thompson, 2011</xref>). F=&#x3b2;<sup>2</sup> (exposure)/SE<sup>2</sup> (exposure) was used to calculate the strength of the IV (<xref ref-type="bibr" rid="B23">Lawlor et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B5">Burgess et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B54">Zhang et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Mendelian randomization analysis and sensitivity analysis</title>
<p>Inverse-variance-weighted (IVW) method, weighted median method, weighted model, MR-Egger and Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) test were used in this study for Mendelian randomization analysis. The IVW method uses Wald estimators and delta&#x2019;s to compute ratio estimates for each SNP, and then combines estimates from each SNP to obtain primary causation estimates (<xref ref-type="bibr" rid="B4">Burgess et&#xa0;al., 2013</xref>). Compared with the other four methods, IVW provided more accurate effect estimates and was therefore chosen as the primary method of analysis, with the other methods used as supplementary validation of IVW (<xref ref-type="bibr" rid="B2">Bowden et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B22">Larsson et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B50">Yavorska and Burgess, 2017</xref>). The MR online power calculation tool (<ext-link ext-link-type="uri" xlink:href="https://shiny.cnsgenomics.com/mRnd/">https://shiny.cnsgenomics.com/mRnd/</ext-link>) was used to calculate the statistical power of the causal effect estimates (<xref ref-type="bibr" rid="B3">Burgess, 2014</xref>).</p>
<p>In addition, as the Inverse Variance Weighted method may be subject to invalid instrument bias or pleiotropy, this study tested the validity and robustness of the IVW results through sensitivity analysis. Firstly, the potential heterogeneity of the MR analysis results was quantified and tested using Cochran&#x2019;s Q. Secondly, the horizontal pleiotropy of the results was assessed using the MR Egger intercept test and the MR PRESSO global test, with p &lt; 0.05 as statistically significant (<xref ref-type="bibr" rid="B7">Burgess and Thompson, 2017</xref>). By setting the number of distributions to 10,000, the MR-PRESSO outlier test was also used to adjust for horizontal pleiotropy by detecting and removing outliers (<xref ref-type="bibr" rid="B46">Verbanck et&#xa0;al., 2018</xref>). In parallel, we assessed the effect of abnormal SNPs on the results of Mendelian randomization using leave-one-out analysis. To further rule out confounding, instrumental variables with significant MR estimates related to risk factors for bipolar disorder (smoking, obesity, type 2 diabetes) were examined and excluded using the PhenoScanner, and re-tested to see if the causal effects remained significant (<xref ref-type="bibr" rid="B19">Kamat et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B47">Vermeulen et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B34">Miola et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Statistical analysis</title>
<p>To obtain more rigorous conclusions, we corrected the P-values using the Bonferroni method. Considering that each character level (phylum, class, order, family and genus) includes several gut microbial taxa, the corrected threshold for each character level should be 0.05/N, where N is the number of taxa included in that character level. Thus, the corrected thresholds for the phylum, class, order, family and genus levels are 5.56 &#xd7; 10<sup>-3</sup> (0.05/9), 3.13 &#xd7; 10<sup>-3</sup> (0.05/16), 2.50 &#xd7; 10<sup>-3</sup> (0.05/20), 1.56 &#xd7; 10<sup>-3</sup> (0.05/32) and 4.20 &#xd7; 10<sup>-4</sup> (0.05/119) respectively. MR results with p-values less than the Bonferroni correction threshold were considered significant. MR results with p-values &lt; 0.05 were considered nominally significant (<xref ref-type="bibr" rid="B26">Liu et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B29">Luo et&#xa0;al., 2023</xref>). A p-value &lt; 0.05 was considered statistically significant for sensitivity analysis in this study. The association between gut microbiota and bipolar disorder was expressed as an odds ratio (OR) with its 95% confidence interval (CI).</p>
<p>All of the above analyses were primarily performed using the Two-Sample-MR package (version 0.5.7) with R software (version 4.2.3).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Details of IVs</title>
<p>Through rigorous screening in the previous section, 2527 SNPs were identified as instrumental variables. The phylum, class, order, family and genus levels of the gut microbiota contained 122, 221, 272, 432 and 1480 instrumental variables, respectively. Details of the IVs are provided in <xref ref-type="supplementary-material" rid="SM1">
<bold>Table S2</bold>
</xref>.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>MR analysis</title>
<p>The results of the preliminary analysis of the relationship between gut microbiota and bipolar disorder are shown in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Table S3</bold>
</xref>.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Preliminary MR estimates for the associations between gut microbiota and the risk of bipolar disorder. From the inner to outer circles, they represent the estimates of: MR-Egger, weighted median, inverse-variance weighted methods, MR-PRESSO and weighted mode, respectively. And the shades of color reflect the magnitude of the p-value.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="frmbi-02-1249518-g002.tif"/>
</fig>
<p>We used IVW as the primary method for MR analysis of the 196 taxa tested. We detected a total of 16 taxa with P values &lt; 0.05 for MR analysis results, and of these 16 taxa with nominal significance, we did not find any taxa with P values less than the Bonferroni correction threshold for MR analysis results. As shown in the sensitivity analysis below, the <italic>Ruminococcaceae NK4A214 group</italic> was found to be horizontally pleiotropic in the MR-Egger intercept test. The <italic>Ruminococcaceae UCG-003</italic> and <italic>Bacillales</italic> were found to be horizontally pleiotropic in the MR-PRESSO global test. These three taxa are therefore removed from the 16 taxa of nominal significance. So after removing these 3 taxa, we ended up with 13 nominally significant gut microbiota. <italic>Prevotella 7</italic> (OR=1.09, 95%CI=1.01-1.17, P=0.027), <italic>Peptococcus</italic> (OR=1.12, 95%CI=1.04-1.21, P=0.003), <italic>Butyricimonas</italic> (OR=1.15, 95%CI=1.02-1.29, P=0.021), <italic>Desulfovibrionales</italic> (OR=1.15, 95%CI=1.00-1.32, P=0.049), <italic>Eubacterium xylanophilum group</italic> (OR=1.16, 95%CI=1.01-1.33, P=0.032), <italic>Betaproteobacteria</italic> (OR=1.17, 95%CI=1.02-1.33, P=0.027), <italic>Acidaminococcaceae</italic> (OR=1.19, 95%CI=1.02-1.40, P=0.026), <italic>Roseburia</italic> (OR=1.20, 95%CI=1.03-1.41, P=0.018), <italic>Burkholderiales</italic> (OR=1.22, 95%CI=1.05-1.41, P=0.008) and <italic>Terrisporobacter</italic> (OR=1.25, 95%CI=1.04-1.49, P=0.016) had a potential causal effect on the increased risk of BD, whereas <italic>Ruminiclostridium 5</italic> (OR=0.86, 95%CI=0.75-0.98, P=0.028), <italic>Candidatus Soleaferrea</italic> (OR=0.91, 95%CI=0.84-0.98, P=0.020), <italic>Victivallis</italic> (OR=0.92, 95% CI=0.86-1.00, P=0.036) had a potential causal effect on the decreased risk of BD (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). The MR results of the Weighted Median, Weighted Mode, MR-Egger and MR-PRESSO methods were then used as additional validation of the IVW. Of the 13 taxa with solid MR results in IVW, four taxa (<italic>Betaproteobacteria, Butyricimonas, Candidatus Soleaferrea</italic> and <italic>Burkholderiales</italic>) showed MR-Egger results that were not parallel to those in IVW. Normally, in this case, we would need to re-examine the instrumental variables at more stringent thresholds (<xref ref-type="bibr" rid="B10">Chen et&#xa0;al., 2021</xref>). However, these four taxa already contain few instrumental variables, and it would be difficult to ensure the statistical power of the MR results if the number of instrumental variables were further reduced. 1 &#xd7; 10<sup>-5</sup> is the threshold chosen for most Mendelian randomization studies of the gut microbiota (<xref ref-type="bibr" rid="B52">Yu et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B53">Zeng et&#xa0;al., 2023</xref>). In addition, the causal effects of the IVW analysis were more precise than those of the MR-Egger analysis. Finally, this situation was already observed in the study by Luo et&#xa0;al. who ultimately chose to retain taxa for which the MR-Egger results did not parallel the IVW results (<xref ref-type="bibr" rid="B29">Luo et&#xa0;al., 2023</xref>). Thus, in the absence of heterogeneity and horizontal pleiotropy, it was ultimately acceptable to retain the IVW results for these four taxa.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Forest plots of MR results for thirteen gut microbiota in bipolar disorder. Method, statistical analysis methods; OR, odds ratio; 95%CI, 95% confidence interval; P, significance P-value; Power, the statistical power of causal effect estimates.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="frmbi-02-1249518-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Sensitivity analysis</title>
<p>As MR results can be affected by invalid instrument bias or pleiotropy, this study examines the validity and robustness of the results through sensitivity analysis. With the exception of the <italic>Ruminococcaceae NK4A214 group, Ruminococcaceae UCG-003</italic> and <italic>Bacillales</italic>, none of the 13 gut microbial taxa were found to be horizontally pleiotropic in the MR-Egger intercept test and the MR-PRESSO global test (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> visually demonstrates that the MR results are not affected by horizontal pleiotropy. For these 13 taxa, the Cochran&#x2019;s Q test and funnel plots provided no evidence for the presence of heterogeneity (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1</bold>
</xref>). In addition, the leave-one-out analysis demonstrates the robustness of the MR results, as the exclusion of any of the instrumental variables does not fundamentally affect the results (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2</bold>
</xref>). The visualisation results of the remaining analyses are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Figures S3, 4</bold>
</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Sensitivity analysis for 13 gut microbiota taxa associated with bipolar disorder.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">id.exposure</th>
<th valign="top" align="left">Cochran&#x2019;s Q</th>
<th valign="top" align="left">Cochran&#x2019;s Q pval</th>
<th valign="top" align="left">Egger_intercept</th>
<th valign="top" align="left">Egger_intercept pval</th>
<th valign="top" align="left">MR-PRESSO global test pval</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Betaproteobacteria</td>
<td valign="top" align="left">11.65</td>
<td valign="top" align="left">0.63</td>
<td valign="top" align="left">0.021</td>
<td valign="top" align="left">0.21</td>
<td valign="top" align="left">0.65</td>
</tr>
<tr>
<td valign="top" align="left">Acidaminococcaceae</td>
<td valign="top" align="left">5.77</td>
<td valign="top" align="left">0.57</td>
<td valign="top" align="left">-0.008</td>
<td valign="top" align="left">0.71</td>
<td valign="top" align="left">0.62</td>
</tr>
<tr>
<td valign="top" align="left">Eubacterium xylanophilum group</td>
<td valign="top" align="left">7.96</td>
<td valign="top" align="left">0.72</td>
<td valign="top" align="left">-0.010</td>
<td valign="top" align="left">0.56</td>
<td valign="top" align="left">0.74</td>
</tr>
<tr>
<td valign="top" align="left">Butyricimonas</td>
<td valign="top" align="left">21.49</td>
<td valign="top" align="left">0.16</td>
<td valign="top" align="left">0.017</td>
<td valign="top" align="left">0.35</td>
<td valign="top" align="left">0.19</td>
</tr>
<tr>
<td valign="top" align="left">Candidatus Soleaferrea</td>
<td valign="top" align="left">14.84</td>
<td valign="top" align="left">0.46</td>
<td valign="top" align="left">-0.030</td>
<td valign="top" align="left">0.09</td>
<td valign="top" align="left">0.47</td>
</tr>
<tr>
<td valign="top" align="left">Peptococcus</td>
<td valign="top" align="left">10.94</td>
<td valign="top" align="left">0.76</td>
<td valign="top" align="left">-0.001</td>
<td valign="top" align="left">0.95</td>
<td valign="top" align="left">0.77</td>
</tr>
<tr>
<td valign="top" align="left">Prevotella 7</td>
<td valign="top" align="left">9.17</td>
<td valign="top" align="left">0.52</td>
<td valign="top" align="left">-0.001</td>
<td valign="top" align="left">0.98</td>
<td valign="top" align="left">0.55</td>
</tr>
<tr>
<td valign="top" align="left">Roseburia</td>
<td valign="top" align="left">23.72</td>
<td valign="top" align="left">0.10</td>
<td valign="top" align="left">0.000</td>
<td valign="top" align="left">0.99</td>
<td valign="top" align="left">0.11</td>
</tr>
<tr>
<td valign="top" align="left">Ruminiclostridium 5</td>
<td valign="top" align="left">13.60</td>
<td valign="top" align="left">0.48</td>
<td valign="top" align="left">-0.002</td>
<td valign="top" align="left">0.88</td>
<td valign="top" align="left">0.50</td>
</tr>
<tr>
<td valign="top" align="left">Terrisporobacter</td>
<td valign="top" align="left">9.71</td>
<td valign="top" align="left">0.08</td>
<td valign="top" align="left">-0.002</td>
<td valign="top" align="left">0.95</td>
<td valign="top" align="left">0.16</td>
</tr>
<tr>
<td valign="top" align="left">Victivallis</td>
<td valign="top" align="left">13.21</td>
<td valign="top" align="left">0.28</td>
<td valign="top" align="left">-0.006</td>
<td valign="top" align="left">0.87</td>
<td valign="top" align="left">0.31</td>
</tr>
<tr>
<td valign="top" align="left">Burkholderiales</td>
<td valign="top" align="left">12.18</td>
<td valign="top" align="left">0.43</td>
<td valign="top" align="left">0.025</td>
<td valign="top" align="left">0.14</td>
<td valign="top" align="left">0.47</td>
</tr>
<tr>
<td valign="top" align="left">Desulfovibrionales</td>
<td valign="top" align="left">14.18</td>
<td valign="top" align="left">0.29</td>
<td valign="top" align="left">0.001</td>
<td valign="top" align="left">0.97</td>
<td valign="top" align="left">0.33</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Radial plots of MR results for thirteen gut microbiota in bipolar disorder. <bold>(A)</bold> Radial estimate for Betaproteobacteria; <bold>(B)</bold> Radial estimate for Acidaminococcaceae; <bold>(C)</bold> Radial estimate for Eubacterium xylanophilum group; <bold>(D)</bold> Radial estimate for Butyricimonas; <bold>(E)</bold> Radial estimate for CandidatusSoleaferrea; <bold>(F)</bold> Radial estimate for Peptococcus; <bold>(G)</bold> Radial estimate for Prevotella 7; <bold>(H)</bold> Radial estimate for Roseburia; <bold>(I)</bold> Radial estimate for Ruminiclostridium 5; <bold>(J)</bold> Radial estimate for Terrisporobacter; <bold>(K)</bold> Radial estimate for Victivallis; <bold>(L)</bold> Radial estimate for Burkholderiales; <bold>(M)</bold> Radial estimate for Desulfovibrionales.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="frmbi-02-1249518-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Replicated analysis after removing confounders-related Ivs</title>
<p>To further rule out confounding, we examined instrumental variables of 13 gut microbiota taxa associated with bipolar disorder using the PhenoScanner. Of these, rs6058181, rs113054641, rs72814525, rs12500231, rs56349194 were associated with obesity, rs45497800 with smoking and rs6494306 with type 2 diabetes. After removing these instrumental variables associated with confounders, the causal relationships between the 13 gut microbial taxa and BD were reassessed. The results showed that the causal relationships of the remaining gut microbial taxa remained significant, with the exception of <italic>Acidaminococcaceae</italic> and <italic>Victivallis</italic> (<xref ref-type="supplementary-material" rid="SM1">
<bold>Table S4</bold>
</xref>; <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Forest plots of MR results for thirteen gut microbiota in bipolar disorder after removing confounding IVs. Method, statistical analysis methods; OR, odds ratio; 95%CI, 95% confidence interval; P, significance P-value; Power, the statistical power of causal effect estimates.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="frmbi-02-1249518-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>After removing 15 unknown taxa, we used MR to analyse the causal relationship between the remaining 196 gut microbiota and bipolar disorder. Finally, we identified a total of 13 gut microbiota that were nominally causally related. Of these, <italic>Betaproteobacteria, Acidaminococcaceae, Eubacterium xylanophilum group, Butyricimonas, Peptococcus, Prevotella 7, Roseburia, Terrisporobacter, Burkholderiales</italic> and <italic>Desulfovibrionales</italic> had a potential causal effect on increased risk of BD, while <italic>Candidatus Soleaferrea, Ruminiclostridium 5</italic> and <italic>Victivallis</italic> had a potential causal effect on decreased risk of BD. The results suggest that the gut microbiota is both a potential marker for early identification of individuals at risk of BD and a target for optimal control strategies.</p>
<p>Many observational studies have found that changes in the gut microbiota are strongly associated with BD. A study by Vinberg et&#xa0;al. found that twins with bipolar disorder not only had reduced gut microbiota diversity compared to healthy twins, but also had significantly altered abundance of some gut microbiota (<xref ref-type="bibr" rid="B49">Vinberg et&#xa0;al., 2019</xref>). In a study of 234 cases of acute mania in bipolar disorder, antibiotic use was strongly associated with the induction and severity of acute mania in bipolar disorder (<xref ref-type="bibr" rid="B51">Yolken et&#xa0;al., 2016</xref>). Because of the limitations of observational studies, we conducted a large-scale systematic analysis of 196 gut microbiota taxa at the genetic level.</p>
<p>Our study identified 13 gut microbial taxa with nominal causal relationships, some of which were related to previous findings. For example, Lu et&#xa0;al. found significantly increased gut abundance of <italic>Prevotella</italic> in patients with BD compared to healthy controls, confirming the results of the present study (<xref ref-type="bibr" rid="B27">Lu et&#xa0;al., 2019</xref>). Hu et&#xa0;al. found significantly lower gut abundance of <italic>Roseburia</italic> in patients with BD compared to healthy controls, which contradicts the results of the present study (<xref ref-type="bibr" rid="B17">Hu et&#xa0;al., 2019</xref>). While some gut microbial taxa have been found to be associated with BD patients, such as a meta-analysis of 59 case-control studies that found an enrichment of <italic>Actinobacteria, Oscillibacter, Megasphaera, Enterococcus</italic> and a depletion of <italic>Faecalibacterium</italic> in BD patients, similar results were not found in the present study (<xref ref-type="bibr" rid="B36">Nikolova et&#xa0;al., 2021</xref>). This difference between genetically predicted and clinically observed outcomes may be due to the complex interactions between the gut microbiota. Further prospective randomised controlled trials are needed to validate this issue.</p>
<p>In recent years, as research has progressed, some evidence has emerged about the mechanisms by which the gut microbiota affect bipolar disorder. (i) Ecological dysbiosis of the microbiota leads to increased secretion of LPS and its entry into the somatic circulation. Once in the circulation, LPS binds to Toll-like receptor 4 (TLR4) and initiates inflammatory signalling leading to the release of a number of inflammatory factors such as IL-6 and IL-1 (<xref ref-type="bibr" rid="B24">Leblhuber et&#xa0;al., 2021</xref>). These inflammatory factors, which cross the blood-brain barrier and enter the brain tissue, can cause neuroinflammation, nerve damage and other manifestations that affect central function (<xref ref-type="bibr" rid="B18">Huang et&#xa0;al., 2021</xref>). (ii) The gut microbiota can directly or indirectly produce neurotransmitters (e.g. GABA, 5-HT, dopamine) that affect brain activity and may influence the development of BD by regulating systemic and central neurotransmitter concentrations. In addition, as the vagus nerve has sensory afferent functions, gut microbiota may influence the activity of brain functions by activating the vagus nerve (<xref ref-type="bibr" rid="B15">Gondalia et&#xa0;al., 2019</xref>). (iii) Gut microbiota may influence episodes of bipolar disorder by activating the hypothalamic-pituitary-adrenal (HPA) axis and modulating levels of brain-derived neurotrophic factor (BDNF) (<xref ref-type="bibr" rid="B44">Sudo et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B31">Maqsood and Stone, 2016</xref>). (iv) Gut microbiota can influence the uptake and utilisation of tryptophan, a key signalling molecule in the gut-brain axis involved in mood regulation (<xref ref-type="bibr" rid="B1">Asan et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B37">O'Mahony et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B45">Sun et&#xa0;al., 2019</xref>).</p>
<p>Although our results found a causal association between gut microbiota and bipolar disorder, our study has some limitations. First, MR results may be biased if sample overlap occurs in Mendelian randomisation studies. In the present study, although we could not explicitly calculate the sample overlap rate, the GWAS summary statistics of gut microbiota and bipolar disorder were obtained from completely different databases, and it is unlikely that sample overlap occurred. In addition, as the GWAS data did not provide detailed individual information, we were unable to perform further subgroup analyses based on factors such as gender and age. Although there are some limitations to this study, a number of sensitivity analyses have confirmed the robustness and reliability of the findings, and therefore this study is valuable.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>The present study demonstrated a causal relationship between gut microbiota and bipolar disorder using MR analysis. Specifically, <italic>Betaproteobacteria, Acidaminococcaceae, Eubacterium xylanophilum group, Butyricimonas, Peptococcus, Prevotella 7, Roseburia, Terrisporobacter, Burkholderiales</italic> and <italic>Desulfovibrionales</italic> increased the risk of BD, while <italic>Candidatus Soleaferrea, Ruminiclostridium 5 and Victivallis</italic> decreased the risk of BD. The greatest value of our research is to provide new biomarkers and potential therapeutic targets for the prevention and treatment of BD.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>Publicly available datasets were analyzed in this study. This data can be found here: <ext-link ext-link-type="uri" xlink:href="https://mibiogen.gcc.rug.nl">https://mibiogen.gcc.rug.nl</ext-link> <ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/">https://gwas.mrcieu.ac.uk/</ext-link>.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>RX and X-JW designed the study, contributed to the data analysis, and wrote the manuscript. SL, L-YL and YZ contributed to the data analysis and data interpretation. B-QF and G-CL contributed to manuscript writing and revision of the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We are grateful to the participants in the MRC-IEU Consortium, MiBioGen consortium and to all the researchers who worked on the data collection.</p>
</ack>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/frmbi.2023.1249518/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/frmbi.2023.1249518/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.zip" id="SM1" mimetype="application/zip"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asan</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Steinke</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lesch</surname> <given-names>K. P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety</article-title>. <source>Histochem. Cell Biol.</source> <volume>139</volume> (<issue>6</issue>), <fpage>785</fpage>&#x2013;<lpage>813</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00418-013-1081-1</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowden</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Davey Smith</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Haycock</surname> <given-names>P. C.</given-names>
</name>
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator</article-title>. <source>Genet. Epidemiol.</source> <volume>40</volume> (<issue>4</issue>), <fpage>304</fpage>&#x2013;<lpage>314</lpage>. doi: <pub-id pub-id-type="doi">10.1002/gepi.21965</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome</article-title>. <source>Int. J. Epidemiol.</source> <volume>43</volume> (<issue>3</issue>), <fpage>922</fpage>&#x2013;<lpage>929</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ije/dyu005</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Butterworth</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>S. G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mendelian randomization analysis with multiple genetic variants using summarized data</article-title>. <source>Genet. Epidemiol.</source> <volume>37</volume> (<issue>7</issue>), <fpage>658</fpage>&#x2013;<lpage>665</lpage>. doi: <pub-id pub-id-type="doi">10.1002/gepi.21758</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Small</surname> <given-names>D. S.</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>S. G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A review of instrumental variable estimators for Mendelian randomization</article-title>. <source>Stat. Methods Med. Res.</source> <volume>26</volume> (<issue>5</issue>), <fpage>2333</fpage>&#x2013;<lpage>2355</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0962280215597579</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>S. G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Avoiding bias from weak instruments in Mendelian randomization studies</article-title>. <source>Int. J. Epidemiol.</source> <volume>40</volume> (<issue>3</issue>), <fpage>755</fpage>&#x2013;<lpage>764</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ije/dyr036</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>S. G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Interpreting findings from Mendelian randomization using the MR-Egger method</article-title>. <source>Eur. J. Epidemiol.</source> <volume>32</volume> (<issue>5</issue>), <fpage>377</fpage>&#x2013;<lpage>389</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10654-017-0255-x</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busnelli</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Manzini</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chiesa</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The gut microbiota affects host pathophysiology as an endocrine organ: A focus on cardiovascular disease</article-title>. <source>Nutrients</source> <volume>12</volume> (<issue>1</issue>), <page-range>79</page-range>. doi: <pub-id pub-id-type="doi">10.3390/nu12010079</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caruso</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Lo</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>N&#xfa;&#xf1;ez</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Host-microbiota interactions in inflammatory bowel disease</article-title>. <source>Nat. Rev. Immunol.</source> <volume>20</volume> (<issue>7</issue>), <fpage>411</fpage>&#x2013;<lpage>426</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41577-019-0268-7</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Diao</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Kidney damage causally affects the brain cortical structure: A Mendelian randomization study</article-title>. <source>EBioMedicine</source> <volume>72</volume>, <fpage>103592</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ebiom.2021.103592</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daghlas</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Lane</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Saxena</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Vetter</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Genetically proxied diurnal preference, sleep timing, and risk of major depressive disorder</article-title>. <source>JAMA Psychiatry</source> <volume>78</volume> (<issue>8</issue>), <fpage>903</fpage>&#x2013;<lpage>910</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2021.0959</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Davey Smith</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians</article-title>. <source>Bmj</source> <volume>362</volume>, <fpage>k601</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.k601</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delzenne</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Neyrinck</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>B&#xe4;ckhed</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Cani</surname> <given-names>P. D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Targeting gut microbiota in obesity: effects of prebiotics and probiotics</article-title>. <source>Nat. Rev. Endocrinol.</source> <volume>7</volume> (<issue>11</issue>), <fpage>639</fpage>&#x2013;<lpage>646</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrendo.2011.126</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Pedersen</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Gut microbiota in human metabolic health and disease</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>19</volume> (<issue>1</issue>), <fpage>55</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-020-0433-9</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gondalia</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Parkinson</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Stough</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Scholey</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy</article-title>. <source>Psychopharmacol. (Berl)</source> <volume>236</volume> (<issue>5</issue>), <fpage>1433</fpage>&#x2013;<lpage>1443</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00213-019-05248-6</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Rong</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Mendelian randomization analyses support causal relationships between brain imaging-derived phenotypes and risk of psychiatric disorders</article-title>. <source>Nat. Neurosci.</source> <volume>25</volume> (<issue>11</issue>), <fpage>1519</fpage>&#x2013;<lpage>1527</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41593-022-01174-7</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sublette</surname> <given-names>M. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Gut microbiota changes in patients with bipolar depression</article-title>. <source>Adv. Sci. (Weinh)</source> <volume>6</volume> (<issue>14</issue>), <fpage>1900752</fpage>. doi: <pub-id pub-id-type="doi">10.1002/advs.201900752</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms</article-title>. <source>CNS Neurosci. Ther.</source> <volume>27</volume> (<issue>1</issue>), <fpage>36</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1111/cns.13569</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamat</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Blackshaw</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Young</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Surendran</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Danesh</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations</article-title>. <source>Bioinformatics</source> <volume>35</volume> (<issue>22</issue>), <fpage>4851</fpage>&#x2013;<lpage>4853</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btz469</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirkpatrick</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>B. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Inflammation and schizophrenia</article-title>. <source>Schizophr. Bull.</source> <volume>39</volume> (<issue>6</issue>), <fpage>1174</fpage>&#x2013;<lpage>1179</lpage>. doi: <pub-id pub-id-type="doi">10.1093/schbul/sbt141</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurilshikov</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Medina-Gomez</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Bacigalupe</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Radjabzadeh</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Demirkan</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Large-scale association analyses identify host factors influencing human gut microbiome composition</article-title>. <source>Nat. Genet.</source> <volume>53</volume> (<issue>2</issue>), <fpage>156</fpage>&#x2013;<lpage>165</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41588-020-00763-1</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larsson</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Traylor</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Malik</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Dichgans</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Markus</surname> <given-names>H. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis</article-title>. <source>Bmj</source> <volume>359</volume>, <fpage>j5375</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.j5375</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawlor</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Harbord</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Sterne</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Timpson</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Davey Smith</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Mendelian randomization: using genes as instruments for making causal inferences in epidemiology</article-title>. <source>Stat. Med.</source> <volume>27</volume> (<issue>8</issue>), <fpage>1133</fpage>&#x2013;<lpage>1163</lpage>. doi: <pub-id pub-id-type="doi">10.1002/sim.3034</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leblhuber</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Ehrlich</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Steiner</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Geisler</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Fuchs</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lanser</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The immunopathogenesis of alzheimer's disease is related to the composition of gut microbiota</article-title>. <source>Nutrients</source> <volume>13</volume> (<issue>2</issue>), <page-range>361</page-range>. doi: <pub-id pub-id-type="doi">10.3390/nu13020361</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Sears</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Maruthur</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Gut microbiome and its role in obesity and insulin resistance</article-title>. <source>Ann. N Y Acad. Sci.</source> <volume>1461</volume> (<issue>1</issue>), <fpage>37</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1111/nyas.14107</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X.</given-names>
</name>
<name>
<surname>He</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Assessing the relationship between gut microbiota and irritable bowel syndrome: a two-sample Mendelian randomization analysis</article-title>. <source>BMC Gastroenterol.</source> <volume>23</volume> (<issue>1</issue>), <fpage>150</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12876-023-02791-7</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Gut microbiota in bipolar depression and its relationship to brain function: an advanced exploration</article-title>. <source>Front. Psychiatry</source> <volume>10</volume>, <elocation-id>784</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2019.00784</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Leukocyte telomere length and bipolar disorder risk: evidence from Mendelian randomization analysis</article-title>. <source>PeerJ</source> <volume>11</volume>, <elocation-id>e15129</elocation-id>. doi: <pub-id pub-id-type="doi">10.7717/peerj.15129</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>13</volume>, <elocation-id>1142140</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2023.1142140</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahar</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Bambico</surname> <given-names>F. R.</given-names>
</name>
<name>
<surname>Mechawar</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Nobrega</surname> <given-names>J. N.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>38</volume>, <fpage>173</fpage>&#x2013;<lpage>192</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.11.009</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maqsood</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Stone</surname> <given-names>T. W.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The gut-brain axis, BDNF, NMDA and CNS disorders</article-title>. <source>Neurochem. Res.</source> <volume>41</volume> (<issue>11</issue>), <fpage>2819</fpage>&#x2013;<lpage>2835</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-016-2039-1</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maynard</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Elson</surname> <given-names>C. O.</given-names>
</name>
<name>
<surname>Hatton</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Weaver</surname> <given-names>C. T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Reciprocal interactions of the intestinal microbiota and immune system</article-title>. <source>Nature</source> <volume>489</volume> (<issue>7415</issue>), <fpage>231</fpage>&#x2013;<lpage>241</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature11551</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McIntyre</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Berk</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Brietzke</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Goldstein</surname> <given-names>B. I.</given-names>
</name>
<name>
<surname>L&#xf3;pez-Jaramillo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kessing</surname> <given-names>L. V.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Bipolar disorders</article-title>. <source>Lancet</source> <volume>396</volume> (<issue>10265</issue>), <fpage>1841</fpage>&#x2013;<lpage>1856</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(20)31544-0</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miola</surname> <given-names>A.</given-names>
</name>
<name>
<surname>De Filippis</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Veldic</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Winham</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Mendoza</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>The genetics of bipolar disorder with obesity and type 2 diabetes</article-title>. <source>J. Affect. Disord.</source> <volume>313</volume>, <fpage>222</fpage>&#x2013;<lpage>231</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jad.2022.06.084</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyauchi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Shimokawa</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Steimle</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Desai</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Ohno</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The impact of the gut microbiome on extra-intestinal autoimmune diseases</article-title>. <source>Nat. Rev. Immunol.</source> <volume>23</volume> (<issue>1</issue>), <fpage>9</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41577-022-00727-y</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolova</surname> <given-names>V. L.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>M. R. B.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Cleare</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Stone</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Young</surname> <given-names>A. H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Perturbations in gut microbiota composition in psychiatric disorders: A review and meta-analysis</article-title>. <source>JAMA Psychiatry</source> <volume>78</volume> (<issue>12</issue>), <fpage>1343</fpage>&#x2013;<lpage>1354</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2021.2573</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Mahony</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Borre</surname> <given-names>Y. E.</given-names>
</name>
<name>
<surname>Dinan</surname> <given-names>T. G.</given-names>
</name>
<name>
<surname>Cryan</surname> <given-names>J. F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Serotonin, tryptophan metabolism and the brain-gut-microbiome axis</article-title>. <source>Behav. Brain Res.</source> <volume>277</volume>, <fpage>32</fpage>&#x2013;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2014.07.027</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Painold</surname> <given-names>A.</given-names>
</name>
<name>
<surname>M&#xf6;rkl</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kashofer</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Halwachs</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Dalkner</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Bengesser</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode</article-title>. <source>Bipolar Disord.</source> <volume>21</volume> (<issue>1</issue>), <fpage>40</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bdi.12682</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Chelvanambi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bhutiani</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kroemer</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Zitvogel</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wargo</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Targeting the gut and tumor microbiota in cancer</article-title>. <source>Nat. Med.</source> <volume>28</volume> (<issue>4</issue>), <fpage>690</fpage>&#x2013;<lpage>703</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41591-022-01779-2</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Ryan</surname> <given-names>P. M.</given-names>
</name>
<name>
<surname>Wiley</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Carafa</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Sherwin</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Moloney</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Gamma-aminobutyric acid-producing lactobacilli positively affect metabolism and depressive-like behaviour in a mouse model of metabolic syndrome</article-title>. <source>Sci. Rep.</source> <volume>9</volume> (<issue>1</issue>), <fpage>16323</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-51781-x</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosoff</surname> <given-names>D. B.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>G. D.</given-names>
</name>
<name>
<surname>Lohoff</surname> <given-names>F. W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: A multivariable mendelian randomization analysis</article-title>. <source>JAMA Psychiatry</source> <volume>78</volume> (<issue>2</issue>), <fpage>151</fpage>&#x2013;<lpage>160</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2020.3554</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sigitova</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Fi&#x161;ar</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Hroudov&#xe1;</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cik&#xe1;nkov&#xe1;</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Raboch</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Biological hypotheses and biomarkers of bipolar disorder</article-title>. <source>Psychiatry Clin. Neurosci.</source> <volume>71</volume> (<issue>2</issue>), <fpage>77</fpage>&#x2013;<lpage>103</lpage>. doi: <pub-id pub-id-type="doi">10.1111/pcn.12476</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stahl</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Breen</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Forstner</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>McQuillin</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ripke</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Trubetskoy</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Genome-wide association study identifies 30 loci associated with bipolar disorder</article-title>. <source>Nat. Genet.</source> <volume>51</volume> (<issue>5</issue>), <fpage>793</fpage>&#x2013;<lpage>803</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41588-019-0397-8</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudo</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chida</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Aiba</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Sonoda</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Oyama</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X. N.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>. <source>J. Physiol.</source> <volume>558</volume> (<issue>Pt 1</issue>), <fpage>263</fpage>&#x2013;<lpage>275</lpage>. doi: <pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Geng</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Supplementation with Lactobacillus kefiranofaciens ZW3 from Tibetan Kefir improves depression-like behavior in stressed mice by modulating the gut microbiota</article-title>. <source>Food Funct.</source> <volume>10</volume> (<issue>2</issue>), <fpage>925</fpage>&#x2013;<lpage>937</lpage>. doi: <pub-id pub-id-type="doi">10.1039/C8FO02096E</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verbanck</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C. Y.</given-names>
</name>
<name>
<surname>Neale</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Do</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases</article-title>. <source>Nat. Genet.</source> <volume>50</volume> (<issue>5</issue>), <fpage>693</fpage>&#x2013;<lpage>698</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41588-018-0099-7</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vermeulen</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Wootton</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Treur</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Sallis</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Zammit</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study</article-title>. <source>Br. J. Psychiatry</source> <volume>218</volume> (<issue>2</issue>), <fpage>88</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1192/bjp.2019.202</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vieta</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Berk</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schulze</surname> <given-names>T. G.</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>A. F.</given-names>
</name>
<name>
<surname>Suppes</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Calabrese</surname> <given-names>J. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Bipolar disorders</article-title>. <source>Nat. Rev. Dis. Primers</source> <volume>4</volume>, <fpage>18008</fpage>. doi: <pub-id pub-id-type="doi">10.1038/nrdp.2018.8</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinberg</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ottesen</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Meluken</surname> <given-names>I.</given-names>
</name>
<name>
<surname>S&#xf8;rensen</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Pedersen</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Kessing</surname> <given-names>L. V.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Remitted affective disorders and high familial risk of affective disorders associate with aberrant intestinal microbiota</article-title>. <source>Acta Psychiatr. Scand.</source> <volume>139</volume> (<issue>2</issue>), <fpage>174</fpage>&#x2013;<lpage>184</lpage>. doi: <pub-id pub-id-type="doi">10.1111/acps.12976</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yavorska</surname> <given-names>O. O.</given-names>
</name>
<name>
<surname>Burgess</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data</article-title>. <source>Int. J. Epidemiol.</source> <volume>46</volume> (<issue>6</issue>), <fpage>1734</fpage>&#x2013;<lpage>1739</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ije/dyx034</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yolken</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Adamos</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Katsafanas</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Khushalani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Origoni</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Savage</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Individuals hospitalized with acute mania have increased exposure to antimicrobial medications</article-title>. <source>Bipolar Disord.</source> <volume>18</volume> (<issue>5</issue>), <fpage>404</fpage>&#x2013;<lpage>409</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bdi.12416</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>A large-scale causal analysis of gut microbiota and delirium: A Mendelian randomization study</article-title>. <source>J. Affect. Disord.</source> <volume>329</volume>, <fpage>64</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jad.2023.02.078</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Roles of gut microbiome in epilepsy risk: A Mendelian randomization study</article-title>. <source>Front. Microbiol.</source> <volume>14</volume>, <elocation-id>1115014</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2023.1115014</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Causal associations between gut microbiome and cardiovascular disease: A Mendelian randomization study</article-title>. <source>Front. Cardiovasc. Med.</source> <volume>9</volume>, <elocation-id>971376</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcvm.2022.971376</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>